(Q39868268)

15 September 2017

title

A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials (English)

1 reference

15 September 2017

Som D Mukherjee

1

1 reference

15 September 2017

Megan E Coombes

2

1 reference

15 September 2017

Mitch Levine

3

1 reference

15 September 2017

Jarold Cosby

4

1 reference

15 September 2017

Brenda Kowaleski

5

1 reference

15 September 2017

Andrew Arnold

6

1 reference

15 September 2017

publication date

29 May 2010

1 reference

Investigational New Drugs

15 September 2017

published in

1 reference

15 September 2017

volume

29

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

1013-1020

1 reference

The price of innovation: new estimates of drug development costs

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

One voice, different tunes: issues raised by dual analysis of a segment of qualitative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Guidelines for submitting adverse event reports for publication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Quality criteria for early signals of possible adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Comparison of two recently published algorithms for assessing the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Adverse drug reactions: definitions, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9456-9

Adverse event reporting in clinical trials: room for improvement

21 January 2018

1 reference

12 December 2020

Adverse drug reactions. A critical review

1 reference

12 December 2020

The ambiguity of adverse drug reactions

1 reference

12 December 2020

Clinical and actuarial judgment

1 reference

12 December 2020

The diagnosis of adverse medical events associated with drug treatment

1 reference

12 December 2020

Agreement of expert judgment in causality assessment of adverse drug reactions

1 reference

12 December 2020

An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity

1 reference

12 December 2020

Adverse drug reactions: scope and limitations of causality assessment and the use of algorithms.

1 reference

12 December 2020

10.1007/S10637-010-9456-9

Identifiers

DOI

1 reference

15 September 2017

1 reference